[HTML][HTML] Transforming growth factor-β1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant …

K Janssens, P ten Dijke, SH Ralston… - Journal of Biological …, 2003 - ASBMB
Transforming growth factor-β1 (TGF-β1) is secreted as a latent precursor, consisting of a
homodimer of the latency-associated peptide and the mature peptide. TGFβ-1 can only exert
its many functions after going from this latent to an active state, in which the binding site of
the mature peptide for its receptor is no longer shielded by the latency-associated peptide.
We and others reported that mutations in TGFB1 cause Camurati-Engelmann disease, a
rare bone disorder. Until now, seven mutations have been published. In this study, we …